Continuous development of colorectal cancer screening programs

References

• Hoff G. Gastrointestinal cancer screening: screening may release new research funding to improve health service also in routine clinics. Scand J Gastroenterol. 2015;50:718–726.
   PubMed Web of Science ®Google Scholar
• Bretthauer M, Kaminski MF, Loberg M, et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med. 2016;176:894–902.
   PubMed Web of Science ®Google Scholar
• Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697–706.
   PubMed Web of Science ®Google Scholar
• Koskenvuo L, Malila N, Pitkaniemi J, et al. Sex differences in faecal occult blood test screening for colorectal cancer. Br J Surg. 2018;106:436–447.
   PubMed Web of Science ®Google Scholar
• Miller EA, Pinsky PF, Schoen RE, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial. Lancet Gastroenterol Hepatol. 2019;4:101–110.
   PubMed Web of Science ®Google Scholar
• Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106–1114.
   PubMed Web of Science ®Google Scholar
• Chacko L, Macaron C, Burke CA. Colorectal cancer screening and prevention in women. Dig Dis Sci. 2015;60:698–710.
   PubMed Web of Science ®Google Scholar
• Holme O, Loberg M, Kalager M, et al. Long-term effectiveness of sigmoidoscopy screening on colorectal cancer incidence and mortality in women and men: a randomized trial. Ann Intern Med. 2018;168:775–782.
   PubMed Web of Science ®Google Scholar
• Brenner H, Haug U, Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol. 2010;105:2457–2464.
   PubMed Web of Science ®Google Scholar
• Garcia-Albeniz X, Hsu J, Bretthauer M, et al. Effectiveness of screening colonoscopy to prevent colorectal cancer among medicare beneficiaries aged 70 to 79 years: a prospective observational study. Ann Intern Med. 2017;166:18–26.
   PubMed Web of Science ®Google Scholar
• Selby K, Jensen CD, Lee JK, et al. Influence of varying quantitative fecal immunochemical test positivity thresholds on colorectal cancer detection: a community-based cohort study. Ann Intern Med. 2018;169:439–447.
   PubMed Web of Science ®Google Scholar
• Malila N, Anttila A, Hakama M. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J Med Screen. 2005;12:28–32.
   PubMed Web of Science ®Google Scholar
• Pitkaniemi J, Seppa K, Hakama M, et al. Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland. BMJ Open Gastroenterol. 2015;2:e000034.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Kraszewska E, Rupinski M, et al. Design of the polish colonoscopy screening program: a randomized health services study. Endoscopy. 2015;47:1144–1150.
   PubMed Web of Science ®Google Scholar
• Holme O, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev. 2013;9:CD009259.
   Google Scholar
• Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100:1103–1110.
   PubMed Web of Science ®Google Scholar
• van Turenhout ST, Oort FA, van der Hulst RW, et al. Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer? BMC Gastroenterol. 2014;14:217.
   PubMed Web of Science ®Google Scholar
• Heldwein W, Dollhopf M, Rosch T, et al. The Munich polypectomy study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy. 2005;37:1116–1122.
   PubMed Web of Science ®Google Scholar
• Rutter MD, Nickerson C, Rees CJ, et al. Risk factors for adverse events related to polypectomy in the English bowel cancer screening programme. Endoscopy. 2014;46:90–97.
   PubMed Web of Science ®Google Scholar
• Lynge E, Tornberg S, von Karsa L, et al. Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer. 2012;48:743–748.
   PubMed Web of Science ®Google Scholar